Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV

The global pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in widespread social and economic disruption. Effective interventions are urgently needed for the prevention and treatment of COVID-19. Neutralizing monoclonal antibodies (mAbs) have d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Jiang, Wen, Wang, Junchao, Jiao, Shasha, Gu, Chenjian, Xu, Wei, Chen, Ben, Wang, Rongjuan, Chen, Huilin, Xie, Youhua, Wang, An, Li, Gang, Zeng, Dadi, Zhang, Jinchao, Zhang, Min, Wang, Shuang, Wang, Mingzhu, Gui, Xun
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2021
Assuntos:
Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8317929/
https://ncbi.nlm.nih.gov/pubmed/34313527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2021.1953683
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados